SNHG6 and colorectal carcinoma: We identified that SNHG6 could act as an oncogenic lncRNA that promoted CRC tumorigenesis and progression via miR-101-3p/Wnt/β-catenin axis, which providing a novel potential therapeutic target for the treatment of CRC.